Seres Therapeutics names Richard Kender as interim CEO
Go back to Seres Therapeutics names Richard Kender as interim CEO| (NASDAQ: BCYC) | Delayed: 4.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.00 | 52 Week High | $ | |||
| Open | $4.00 | 52 Week Low | $ | |||
| Day High | $4.10 | P/E | N/A | |||
| Day Low | $3.98 | EPS | $ | |||
| Volume | 190,102 | |||||
| (NASDAQ: MCRB) | Delayed: 6.99 -0.06 (0.85%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.05 | 52 Week High | $44.51 | |||
| Open | $7.02 | 52 Week Low | $8.05 | |||
| Day High | $7.27 | P/E | N/A | |||
| Day Low | $6.90 | EPS | $0.00 | |||
| Volume | 30,212 | |||||
